Curbstone Financial Management Corp Becton Dickinson & CO Transaction History

Curbstone Financial Management Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 03, 2024	SELL	$225.07 - $246.17 $8,102 - $8,862	-36 Reduced 1.89%	1,872 $437,000
Q1 2023 May 12, 2023	SELL	$229.71 - $259.35 $68,913 - $77,805	-300 Reduced 13.59%	1,908 $472,000
Q4 2022 Jan 19, 2023	SELL	$218.29 - $256.91 $43,658 - $51,382	-200 Reduced 8.31%	2,208 $561,000
Q4 2021 Jan 19, 2022	SELL	$230.08 - $250.94 $920 - $1,003	-4 Reduced 0.17%	2,408 $606,000
Q2 2021 Jul 09, 2021	SELL	$232.65 - $254.58 $29,313 - $32,077	-126 Reduced 4.96%	2,412 $587,000
Q4 2020 Jan 14, 2021	SELL	$221.92 - $245.94 $11,096 - $12,297	-50 Reduced 1.93%	2,538 $635,000
Q3 2020 Oct 02, 2020	SELL	$215.77 - $276.76 $8,630 - $11,070	-40 Reduced 1.52%	2,588 $602,000
Q1 2020 Apr 20, 2020	BUY	$195.69 - $279.01 $21,134 - $30,133	108 Added 4.29%	2,628 $604,000
Q2 2018 Jul 06, 2018	SELL	$208.1 - $233.85 $18,729 - $21,046	-90 Reduced 3.45%	2,520 $604,000
Q1 2018 Apr 10, 2018	BUY	$205.46 - $240.27 $288,671 - $337,579	1,405 Added 116.6%	2,610 $566,000
Q4 2017 Jan 08, 2018	BUY	$189.0 - $222.64 $227,745 - $268,281	1,205	1,205 $258,000

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

Stay updated on Curbstone Financial Management Corp with notifications on news.